Ascenion GmbH, technology transfer partner of the Max Delbrück Center for Molecular Medicine (MDC), has supported the conclusion of an agreement between the MDC and Fate Therapeutics, Inc.
Learn about the milestones we reached together with our partners in 2018, the revenues we generated and interesting emerging trends. The key points at…